Showing 41 - 60 results of 101 for search 'Guide to Pharmacology', query time: 0.05s Refine Results
  1. 41
  2. 42
  3. 43
  4. 44

    Unveiling the toxicity of JWH-018 and JWH-019: Insights from behavioral and molecular studies in vivo and vitro by Fenghua Zhou, Yan Shi, Sujun Tan, Xiaoli Wang, Weicheng Yuan, Shuqi Tao, Ping Xiang, Bin Cong, Chunling Ma, Di Wen

    Published 2025-01-01
    “…These findings shed light on the molecular pharmacology and activation mechanism of SCs for CB1R and should guide further research into the mechanisms underlying their deleterious effects in humans.…”
    Get full text
    Article
  5. 45

    Professional Development of Professors of Medicine for Improving the Teaching-Learning Process by Pedro Miguel Milián Vázquez, Lidia Vázquez Montero, Omeris Mesa González, Magdalena O. Albelo Amor, Helvia M. Reyes Cabrera, José Catalino Bermúdez Martínez

    Published 2014-04-01
    “…The relation between this problem and the improvement of the teaching-learning process of a particular discipline, such as Pharmacology, is addressed. Finally, the conditions that should guide the process of professional development towards this improvement are provided.…”
    Get full text
    Article
  6. 46

    Should we consider microbiota-based interventions as a novel therapeutic strategy for schizophrenia? A systematic review and meta-analysis by Lucas Hassib, Alexandre Kanashiro, João Francisco Cordeiro Pedrazzi, Bárbara Ferreira Vercesi, Sayuri Higa, Íris Arruda, Yago Soares, Adriana de Jesus de Souza, Alceu Afonso Jordão, Francisco Silveira Guimarães, Frederico Rogério Ferreira

    Published 2025-02-01
    “…Finally, we address the main confounding factors identified in our systematic review, highlight key limitations, and offer recommendations to guide future high-quality trials with larger participant cohorts to explore microbiome-based therapies as a primary or adjunctive treatment for schizophrenia.…”
    Get full text
    Article
  7. 47

    Resurgence of Polymyxin B for MDR/XDR Gram-Negative Infections: An Overview of Current Evidence by Suneel Kumar Garg, Omender Singh, Deven Juneja, Niraj Tyagi, Amandeep Singh Khurana, Amit Qamra, Salman Motlekar, Hanmant Barkate

    Published 2017-01-01
    “…Understanding newer evidence on polymyxin B is necessary to guide clinical decision making. Here, we present a literature review of polymyxin B in Gram-negative infections with update on its pharmacology.…”
    Get full text
    Article
  8. 48
  9. 49
  10. 50
  11. 51
  12. 52
  13. 53
  14. 54
  15. 55
  16. 56
  17. 57
  18. 58
  19. 59
  20. 60

    Interventions for the management of post-COVID-19 condition (long COVID): protocol for a living systematic review and network meta-analysis by Paul Garner, Lawrence Mbuagbaw, Jason W Busse, Dena Zeraatkar, Thomas Agoritsas, Ariel Izcovich, Tari Turner, Lyn Turkstra, Roger S McIntyre, Rachel J Couban, Tyler Pitre, Sarah Kirsh, Tanvir Jassal, Michael Ling, Samantha Chakraborty, Signe A Flottorp

    Published 2025-02-01
    “…Trustworthy systematic reviews that clarify the benefits and harms of interventions are critical to promote evidence-based practice.Objective To create and maintain a living systematic review and network meta-analysis addressing the benefits and harms of pharmacologic and non-pharmacologic interventions for the treatment and management of long COVID.Methods Eligible trials will randomise adults with long COVID to pharmacologic or non-pharmacologic interventions, placebo, sham or usual care. …”
    Get full text
    Article